Bill Snyder
-
Releasing a brake that drives obesity and diabetes
Vanderbilt researchers have uncovered a potential new way to help curb the rapidly rising worldwide prevalence of metabolic disorders, including obesity and diabetes. Read MoreSep 6, 2023
-
Study reveals genomic code for sepsis in the lungs and kidneys
Researchers at Vanderbilt University Medical Center and the Nashville Veterans Affairs Medical Center have “cracked” the genomic code for sepsis in the lungs and kidneys. Read MoreAug 21, 2023
-
VUMC receives $28 million to lead national study of COVID-diabetes link
Researchers at Vanderbilt University Medical Center have received a four-year, $28 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases to study the relationship between COVID-19 and diabetes. Read MoreAug 2, 2023
-
Nancy Cox receives American Society of Human Genetics Leadership Award
Nancy Cox, PhD, director of the Vanderbilt Genetics Institute, is the recipient of the 2023 ASHG Leadership Award from the American Society of Human Genetics. Read MoreJul 26, 2023
-
Predicting gene expression may speed discovery: study
Researchers at Vanderbilt University Medical Center and the University of Cambridge have developed a method of or predicting gene expression in hard-to-access tissues like the brain from more accessible tissues, including whole blood. Read MoreJul 20, 2023
-
Study reveals new clue to gastric cancer
Researchers at Vanderbilt University Medical Center have uncovered evidence of fibroblast cells' direct involvement in the development of gastric cancer. Read MoreJul 7, 2023
-
Vanderbilt researchers envision the potential to grow new lungs
Using a four-dimensional microscope that allows them to watch a tissue putting itself together, researchers at Vanderbilt University Medical Center have achieved a rare feat in science — they have shattered a long-standing dogma about how the lung develops. Read MoreJul 5, 2023
-
VUMC, Oxford team develops ‘blueprint’ to block lethal virus
Researchers at Vanderbilt University Medical Center and the University of Oxford have determined how a human monoclonal antibody isolated at Vanderbilt in 2021 can prevent infection by the potentially lethal Sin Nombre virus. Read MoreJun 22, 2023
-
New view of mutations informs disease risk, treatment response
A transcontinental research effort led by scientists from Vanderbilt University Medical Center and the University of Michigan has upended some long-standing assumptions about mutations — how often they occur, what causes them and what they do. Read MoreMay 18, 2023
-
Research identifies new target that may prevent blood cancer
An international coalition of biomedical researchers co-led by Vanderbilt's Alexander Bick, MD, PhD, has determined a new way to measure the growth rate of precancerous clones of blood stem cells that one day could help doctors lower their patients’ risk of blood cancer. Read MoreApr 12, 2023
-
Scientists resurrect a ‘dead’ antibody to study protein
Vanderbilt was part of a multi-center team that resurrected a “dead antibody” to reveal the mysteries of cytochrome c, a versatile protein that is an essential part of the cell’s energy-generating capacity, and of life itself. Read MoreMar 16, 2023
-
Study finds RSV may evade vaccines via rapid mutation
A Vanderbilt study concluded that RSV’s ability to mutate rapidly to escape detection by the body’s immune system makes it more challenging to design and develop vaccines that can stop it from spreading. Read MoreMar 9, 2023
-
Study finds chronically disrupted sleep may increase risk for heart disease
Vanderbilt research found that sleep irregularity — chronically disrupted sleep and highly variable sleep durations night after night — may increase the risk for atherosclerosis. Read MoreFeb 15, 2023
-
Team’s imaging strategy enhances lipedema treatment
A collaborative team at Vanderbilt is transforming the diagnosis and treatment of lipedema, a debilitating, abnormal deposition of fatty tissue that afflicts an estimated 17 million women in the United States. Read MoreFeb 9, 2023
-
Researchers clarify role of blood cell mutations in disease
Vanderbilt researchers have developed a new method to analyze mutations in blood stem cells that can trigger explosive, clonal expansions of abnormal cells. Read MoreFeb 2, 2023
-
Study reveals new genetic disorder that causes susceptibility to opportunistic infections
An international consortium co-led by Vanderbilt's Rubén Martínez-Barricarte has discovered a new genetic disorder that causes immunodeficiency and profound susceptibility to opportunistic infections including a life-threatening fungal pneumonia. Read MoreJan 20, 2023
-
Reduced kidney function may cause cardiovascular disease: study
An international team of investigators has found that mild to moderate reduction in kidney function may cause cardiovascular disease, even in people without symptoms of heart disease or diabetes. Read MoreDec 15, 2022
-
Hawiger still blazing a trail in inflammation research
Vanderbilt research describes a new investigational peptide drug that can penetrate immune and nonimmune cells, and block inflammatory signaling in a preclinical model of atopic dermatitis — eczema. Read MoreNov 10, 2022
-
Study finds Moderna’s COVID-19 vaccine safe and effective for young children
A Vanderbilt study finds that Moderna’s COVID-19 vaccine is safe and effective in children 6 months to 5 years of age. Read MoreNov 4, 2022
-
Vanderbilt’s Crowe receives the Building the Foundation Award from Research!America
Vanderbilt's James Crowe Jr., MD, has received the Building the Foundation Award from Research!America, a national biomedical research advocacy organization. Read MoreOct 6, 2022